Inhibitors of Clostridium histolyticum colagenase

Main Article Content

Sérgio Roberto de Andrade Leite

Abstract

Different substances were tested as inhibitors of Clostridium histolyticum collagenase, both experimental and theoretically. The in vitro collagenase activity, alone and in the presence of inhibitors, was quantified by reaction with bovine collagen and dosage of the releasing amino acids. Collagenaseinhibitor interaction was studied theoretically by docking computational calculations. Only one among the tested substances showed inhibitor activity against the bacterial collagenase.

Metrics

Metrics Loading ...

Article Details

How to Cite
Leite, S. R. de A. (2018). Inhibitors of Clostridium histolyticum colagenase. Eclética Química, 33(4), 47–52. https://doi.org/10.26850/1678-4618eqj.v33.4.2008.p47-52
Section
Original articles

References

I. Mandl, J. MacLennan, E. Howes, R. DeBellis and A. Sohler, J Clin Invest 32 (1953) 1323-1329.

S. Moore and W. H. Stein, J Biol Chem 211 (1954) 907-913.

A.Barracchini, N.Franceschini, G.Minisola, G.C.Pantaleoni, A.Di Giulio, A.Oratore, G.Amicosante, 1999. Meloxicam and Indometacin activity on human matrix metalloproteinases in synovial fluid. In: Greenwald,R.A., Zucker,S., Golub,L.M. (Eds.), Inhibition of matrix metalloproteinases: therapeutic applications. New York Academy of Sciences, New York, pp. 665-666.

L. M. Golub, M. Wolff and H. M. Lee, J. Periodont. Res. 20 (1985) 12-23.

L. M. Golub, S. Ciancio, N. S. Ramamurthy, M. Leung and T. F. McNamara, J. Periodont. Res. 26 (1990) 321-330.

L. M. Golub, T. Sorsa, H. M. Lee, S. Ciancio, D. Sorbi, N. S. Ramamurthy, B. Gruber, T. Salo and Y. T. Konttinen, J. Clin. Periodont. 22 (1995) 100-109.

L.M.Golub, N.S.Ramamurthy, A.Llavaneras, M.E.Ryan, H.M.Lee, Y.Liu, S.Bain, T.Sorsa, 1999. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extraoral bone loss in ovariectomized rats. In: Greenwald,R.A., Zucker,S., Golub,L.M. (Eds.), Inhibition of matrix metalloproteinases: therapeutic applications. New York Academy of Sciences, New York, pp. 290-310.

R. A. Greenwald, L. M. Golub, N. S. Ramamurthy, M. Chowdhury, S. A. Moak and T. Sorsa, Bone 22 (1998) 33-38.

O.Teronen, P.Heikkila, Y.Konttinen, M.Laitinen, T.Salo, R.Hanemaaijer, A.Teronen, T.Sorsa, 1999. MMP inhibition ad

downregulation by biphosphonates. In: Greenwald,R.A., Zucker,S., Golub,L.M. (Eds.), Inhibition of matrix metalloproteinases: therapeutic applications. New York Academy of Sciences, New York, pp. 453-465.

I. Schrödinger, First Discovery: Technical notes for version

8. Schrödinger, Inc., Portland, OR, 2001.

I. Schrödinger, Jaguar User’s Guide. Version 4.1 Schrödinger, Inc., Portland, OR, 2001.

I. Fujitsu, CAChe 5.0 for Windows User Guide Fujitsu Systems Business of America, Inc., 2001.

J. J. Wilson, O. Matsushita, A. Okabe and J. Sakon, The EMBO Journal 22 (2003) 1743-1752.